Investing in our communities
given to projects focused on science, technology, engineering and maths (STEM) education
partnerships across our disease prevention and access programs
Wherever we work in the world, we aim to make a positive impact on our local communities. Our workforce is a force for good, and we encourage and support our employees in taking up volunteering opportunities. We target our global community investment towards supporting science-based education and mentorship, strengthening healthcare in local communities, responding to disaster relief efforts and providing product donations. We also support programmes that improve access to healthcare.
Explore our 2017 community investments
In 2017, we gave $25 million in Community Investment Contributions to more than 900 non-profit organisations in 61 countries around the world. These included:
Funding Red Cross in North Uganda
Providing funding to support the deployment of the British Red Cross's Mass Sanitation Unit to Northern Uganda where it provided sanitation and hygiene services, and health information, to more than 19,000 refugees, and donating medicines worth $4.3 million (US Wholesale Acquisition Cost Value) in response to disasters and humanitarian needs all over the world
Image source: British Red Cross
Advanced Coronary Treatment Foundation in Canada
Supporting the Advanced Coronary Treatment Foundation in Canada to empower 346,000 young people in 1,800 high schools across the country with lifesaving CPR training and heart health knowledge in 2017 (more than 3.9 million young people to date)
Breast Awareness Campaigns in Cambodia
Teaching 8,000 women about the importance of early detection and treatment for breast cancer through our 10-year partnership with AmeriCares and Sihanouk Centre of Hope (SHCH) Hospital in Phnom Pen, Cambodia. We are strengthening existing treatment services while expanding in scale to reach additional patients. Also in the past year, more than 700 women have been evaluated and screened for breast cancer, 576 patients have received ongoing treatment follow-ups for breast cancer and 370 patients have received anti-hormonal therapy.